© 2024 grapl ltd.
The Decentralised Procedure (DCP)
Course Summary
The Decentralised Procedure is one of three routes available to applicants to gain multinational marketing authorisation within the European Economic Area (EEA) on the basis of a single application. It can be used only for a product which has no existing marketing authorisation in any member state. It is similar to the Mutual Recognition Procedure (MRP) but with earlier involvement of the Concerned Member States in the assessment by the Reference Member State. The Coordination Group for Mutual Recognition and Decentralised Procedures (CMD) provides guidance and acts to facilitate agreement among the participating states.
This module describes the roles of the various players in the procedure, the sequence and duration of the stages involved, and the requirements on content, format and timing of submissions. It discusses the special issues that apply to generic products in the DCP.
Purchasing Information
When you have completed your course order, Zenosis will finalise the setup of your course materials and contact you on the email address that you provide in your order. You can expect this process to be completed within one business day (using the UK business calendar) of completing your payment.
It is therefore essential that you use your real email address for your order, or indicate in the purchase notes the email address to be used for the course set-up, and check that any messages from Zenosis or grapl are not lost in your junk or spam folder.
You will have access to the course module(s) for a period of 180 days after your purchase is complete.
Detailed Course Information
Learning Objectives
• Provide an overview of the DCP process.
• Describe the pre-submission and submission actions in relation to timeline deadlines.
• Specify the responsibilities of the Reference Member State (RMS), the Concerned Member States (CMSs) and the applicant.
Who will benefit from this course
This module is primarily aimed at regulatory affairs professionals dealing with marketing authorisation applications and related submissions for regulatory approval in Europe. More generally, it will also be of interest to all those involved in the development and registration of medicinal products.
Module Outline
• Module overview
– Provides an overview of the content of the module and outlines related Zenosis modules.
• An introduction to the Decentralised Procedure
– This session provides background information. It covers products for which the DCP can be used, the types of Marketing Authorisation Application, and characteristics of the application procedure.
• DCP Step 1
– This session takes you through the pre-procedural step and the first assessment stage of the DCP, as far as day 120.
• DCP Step 2
– This session takes you through the second assessment stage and the final step of issuing national licences. Referral of issues to the CMD, and the arbitration process, are also covered.
• Generics and the DCP
– This session gives a brief introduction to generics and the special issues facing generics in the DCP.
• Assessment
– Multiple-choice mastery assessment.
Roles
Regulatory
CPD Points
2
Region
Level
Introductory/Intermediate
Course Study Time
Approx 2 hours
Europe